Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer's disease.

Counts SE, Che S, Ginsberg SD, Mufson EJ.

J Chem Neuroanat. 2011 Oct;42(2):111-7. doi: 10.1016/j.jchemneu.2011.02.004. Epub 2011 Mar 17.

2.

Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.

Perez SE, Getova DP, He B, Counts SE, Geula C, Desire L, Coutadeur S, Peillon H, Ginsberg SD, Mufson EJ.

Am J Pathol. 2012 Feb;180(2):526-40. doi: 10.1016/j.ajpath.2011.10.027. Epub 2011 Dec 3.

3.

Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease.

Mufson EJ, Ma SY, Dills J, Cochran EJ, Leurgans S, Wuu J, Bennett DA, Jaffar S, Gilmor ML, Levey AI, Kordower JH.

J Comp Neurol. 2002 Feb 4;443(2):136-53.

PMID:
11793352
4.

Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease.

Ginsberg SD, Che S, Wuu J, Counts SE, Mufson EJ.

J Neurochem. 2006 Apr;97(2):475-87. Epub 2006 Mar 15.

5.

Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease.

Counts SE, Nadeem M, Wuu J, Ginsberg SD, Saragovi HU, Mufson EJ.

Ann Neurol. 2004 Oct;56(4):520-31.

PMID:
15455399
6.

Cholinotrophic molecular substrates of mild cognitive impairment in the elderly.

Mufson EJ, Counts SE, Fahnestock M, Ginsberg SD.

Curr Alzheimer Res. 2007 Sep;4(4):340-50. Review.

PMID:
17908035
7.

Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease.

Mufson EJ, Ma SY, Cochran EJ, Bennett DA, Beckett LA, Jaffar S, Saragovi HU, Kordower JH.

J Comp Neurol. 2000 Nov 6;427(1):19-30.

PMID:
11042589
8.

Down-regulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer's disease.

Chu Y, Cochran EJ, Bennett DA, Mufson EJ, Kordower JH.

J Comp Neurol. 2001 Aug 27;437(3):296-307.

PMID:
11494257
9.

Galanin fiber hypertrophy within the cholinergic nucleus basalis during the progression of Alzheimer's disease.

Counts SE, Chen EY, Che S, Ikonomovic MD, Wuu J, Ginsberg SD, Dekosky ST, Mufson EJ.

Dement Geriatr Cogn Disord. 2006;21(4):205-14. Epub 2006 Jan 12.

10.

The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease.

Counts SE, Mufson EJ.

J Neuropathol Exp Neurol. 2005 Apr;64(4):263-72. Review.

PMID:
15835262
11.

Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease.

Mufson EJ, Counts SE, Ginsberg SD.

Neurochem Res. 2002 Oct;27(10):1035-48.

PMID:
12462403
12.

Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease.

Counts SE, He B, Che S, Ikonomovic MD, DeKosky ST, Ginsberg SD, Mufson EJ.

Arch Neurol. 2007 Dec;64(12):1771-6.

PMID:
18071042
13.

Progression of tau pathology in cholinergic Basal forebrain neurons in mild cognitive impairment and Alzheimer's disease.

Vana L, Kanaan NM, Ugwu IC, Wuu J, Mufson EJ, Binder LI.

Am J Pathol. 2011 Nov;179(5):2533-50. doi: 10.1016/j.ajpath.2011.07.044. Epub 2011 Sep 23.

14.

Nerve growth factor: structure, function and therapeutic implications for Alzheimer's disease.

Lad SP, Neet KE, Mufson EJ.

Curr Drug Targets CNS Neurol Disord. 2003 Oct;2(5):315-34. Review.

PMID:
14529363
15.

Direct, complex effects of estrogens on basal forebrain cholinergic neurons.

Bora SH, Liu Z, Kecojevic A, Merchenthaler I, Koliatsos VE.

Exp Neurol. 2005 Aug;194(2):506-22.

PMID:
15893308
16.

Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction.

Mufson EJ, Ginsberg SD, Ikonomovic MD, DeKosky ST.

J Chem Neuroanat. 2003 Dec;26(4):233-42. Review.

PMID:
14729126
17.

Trk neurotrophin receptors in cholinergic neurons of patients with Alzheimer's disease.

Boissière F, Hunot S, Faucheux B, Hersh LB, Agid Y, Hirsch EC.

Dement Geriatr Cogn Disord. 1997 Jan-Feb;8(1):1-8.

PMID:
8997546
18.

Reduction in TrkA-immunoreactive neurons is not associated with an overexpression of galaninergic fibers within the nucleus basalis in Down's syndrome.

Sendera TJ, Ma SY, Jaffar S, Kozlowski PB, Kordower JH, Mawal Y, Saragovi HU, Mufson EJ.

J Neurochem. 2000 Mar;74(3):1185-96.

20.

Diminished trkA receptor signaling reveals cholinergic-attentional vulnerability of aging.

Parikh V, Howe WM, Welchko RM, Naughton SX, D'Amore DE, Han DH, Deo M, Turner DL, Sarter M.

Eur J Neurosci. 2013 Jan;37(2):278-93. doi: 10.1111/ejn.12090. Epub 2012 Dec 11.

Supplemental Content

Support Center